Literature DB >> 12716245

Impact of bipolar disorder on a U.S. community sample.

Joseph R Calabrese1, Robert M A Hirschfeld, Michael Reed, Marilyn A Davies, Mark A Frye, Paul E Keck, Lydia Lewis, Susan L McElroy, James P McNulty, Karen D Wagner.   

Abstract

BACKGROUND: Bipolar disorder is a chronic psychiatric illness characterized by depression and at least 1 manic or hypomanic episode during the lifetime of the illness. Bipolar symptoms have been associated with significant functional impairment. We conducted a study to determine the psychosocial impact of bipolar disorder in a U.S. community sample.
METHOD: 3059 subjects were selected from a large epidemiologic study of bipolar prevalence that used the Mood Disorder Questionnaire (MDQ) to screen for bipolar I and II disorder. Subjects were surveyed from April 24, 2001, to August 6, 2001, using the Sheehan Disability Scale and the Social Adjustment Scale-Self Report. Comorbid disease data were also collected.
RESULTS: Of the 3059 subjects surveyed, 2450 (80%) returned completed surveys: 1167 (48%) subjects screened positive for bipolar disorder based on MDQ scores; 1283 (52%) screened negative. MDQ-positive subjects reported significantly (p <.0001) more difficulties with work-related performance, social/leisure activities, and social/family interactions compared with MDQ-negative subjects. Younger subjects, aged 18 to 34 years, reported significantly (p =.003) more symptom days than did older MDQ-positive subjects. MDQ-positive women reported more disruption in social and family life, while MDQ-positive men reported being jailed, arrested, and convicted for crimes. Anxiety (30% vs. 6%), panic attacks (18% vs. 4%), migraine (24% vs. 11%), asthma (17% vs. 10%), and allergies (42% vs. 29%) were significantly (p <.05) more common in MDQ-positive versus MDQ-negative subjects.
CONCLUSION: Bipolar disorder, as identified in a community sample using the Mood Disorder Questionnaire, was significantly associated with negative impact on the performance of work-related, leisure, and interpersonal activities.

Entities:  

Mesh:

Year:  2003        PMID: 12716245     DOI: 10.4088/jcp.v64n0412

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  60 in total

1.  Psychosocial predictors of mood symptoms 1 year after acute phase treatment of bipolar I disorder.

Authors:  Lauren M Weinstock; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2010-03-12       Impact factor: 3.735

2.  Enhancing medication adherence: in older adults with bipolar disorder.

Authors:  Colin A Depp; Barry D Lebowitz
Journal:  Psychiatry (Edgmont)       Date:  2007-06

3.  Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers.

Authors:  Ronald C Kessler; Hagop S Akiskal; Minnie Ames; Howard Birnbaum; Paul Greenberg; Robert M A Hirschfeld; Robert Jin; Kathleen R Merikangas; Gregory E Simon; Philip S Wang
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

4.  Incurring greater health care costs: risk stratification of employees with bipolar disorder.

Authors:  Richard A Brook; Krithika Rajagopalan; Nathan L Kleinman; James E Smeeding; Truman J Brizee; Harold H Gardner
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

5.  Managing bipolar disorder from urgent situations to maintenance therapy.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 6.  Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement.

Authors:  Todd D Gould; Haim Einat
Journal:  Neurosci Biobehav Rev       Date:  2007-05-31       Impact factor: 8.989

7.  Undiagnosed Bipolar Disorder: New Syndromes and New Treatments.

Authors:  Ira D Glick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 8.  Aripiprazole: in acute mania associated with bipolar I disorder.

Authors:  Katherine A Lyseng-Williamson; Caroline M Perry
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Treating bipolar disorder in the primary care setting: the role of aripiprazole.

Authors:  J Sloan Manning; Susan L McElroy
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

10.  The sensitivity and specificity of the mood disorders questionnaire varies with the intensity of mood illness.

Authors:  Karthik S Suresh; R Jeannie Roberts; Rif S El-Mallakh
Journal:  Psychiatr Q       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.